Initiation of Tumor Necrosis Factor-α Antagonists and the Risk of Hospitalization for Infection in Patients With Autoimmune Diseases-Reference-Cited by-同舟云学术

Initiation of Tumor Necrosis Factor-α Antagonists and the Risk of Hospitalization for Infection in Patients With Autoimmune Diseases

Published:2011-12-07 Issue:21 Volume:306 Page:
ISSN:0098-7484
Container-title:JAMA
language:en
Short-container-title:JAMA

Author:

Grijalva Carlos G.,Chen Lang,Delzell Elizabeth,Baddley John W.,Beukelman Timothy,Winthrop Kevin L.,Griffin Marie R.,Herrinton Lisa J.,Liu Liyan,Ouellet-Hellstrom Rita,Patkar Nivedita M.,Solomon Daniel H.,Lewis James D.,Xie Fenglong,Saag Kenneth G.,Curtis Jeffrey R.

Publisher

American Medical Association (AMA)

Subject

General Medicine

Cited by 311 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Association of Cardiovascular Outcomes With Low‐Dose Glucocorticoid Prescription in Patients With Rheumatoid Arthritis;Arthritis & Rheumatology;2024-07-23

2. Comparison of infection risk between enzalutamide and abiraterone in patients with prostate cancer;Cancer;2024-07-21

3. Incidence of serious infections in the working‐age Japanese adult population with rheumatoid arthritis treated with tumor necrosis factor‐α inhibitors and interleukin‐6 inhibitors: A nationwide retrospective cohort study;Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy;2024-06-12

4. A narrative review of the comparative safety of disease-modifying anti-rheumatic drugs used for the treatment of rheumatoid arthritis;Expert Opinion on Drug Safety;2024-05-23

5. Low incidence of invasive fungal infection and risk factors in a large observational cohort of patients initiating tumor necrosis factor-alpha inhibitors for dermatologic conditions;Journal of the American Academy of Dermatology;2024-04